Japanese Trade Distributors Stock News

Buyback completion and growth plans put Dai Nippon Printing in focus Dai Nippon Printing (TSE:7912) has completed a share repurchase of 2,638,400 shares, or 0.61% of outstanding stock, for ¥7,205.51 million, following guidance outlined at its recent Analyst/Investor Day. See our latest analysis for Dai Nippon Printing. The share price of Dai Nippon Printing has eased over the past week, but a 20.72% 1 month share price return and 12.56% year to date share price return sit alongside a 5 year...

Cooling inflation, shifting rate expectations and active central banks are giving investors fresh reasons to look at companies tied to the ChatGPT and AI trend. With energy prices and bond yields moving around, many are searching for businesses that sit at the heart of today’s most widely discussed technologies, from chips and cloud to AI software and large language models. This AI Stocks screener targets exactly that, helping you focus on companies directly involved in building and supplying...

In early July 2026, Komatsu Ltd. completed a share repurchase of 9,586,700 shares for ¥61,707.97 million and issued two unsecured straight bonds totaling ¥50.00 billion, including a ¥20.00 billion green bond due 2029 and a ¥30.00 billion bond due 2031. This combination of balance sheet reshaping through buybacks and the issuance of a labeled green bond highlights Komatsu’s evolving capital structure and sustainability-focused funding approach. We’ll now consider how Komatsu’s completion of...

With inflation readings mixed across regions, bond yields shifting and energy prices affecting policy expectations, many investors are looking for clearer signals in company fundamentals. Cash flow can offer that clarity. Stocks that have solid cash flow potential yet trade below an independent fair value estimate may give you exposure to companies where expectations look relatively muted compared with their underlying cash generation. This article focuses on the Undervalued Stocks Based On...

With inflation readings, bond yields and oil prices pulling markets in different directions, it is easy to feel stuck on the sidelines. The Healthy high growth potential screener offers one way to cut through that noise by highlighting companies where analysts currently expect strong earnings growth over the next 3 years and balance sheets that pass basic financial health checks. This article focuses on that theme and reveals 3 stocks from the screener that stand out for further research,...

As geopolitical tensions in the Middle East and energy market volatility capture global attention, Asian markets have shown mixed performance, with some regions experiencing declines while others see gains driven by technology sectors. In such an environment, dividend stocks can offer a measure of stability and income potential, making them an attractive consideration for investors looking to navigate uncertain times.

SBI Shinsei Bank (TSE:8303) is back in focus after announcing a lower year-end dividend for the fiscal year ended March 2026, citing a prior two-for-one stock split and confirming a sizeable share buyback program. See our latest analysis for SBI Shinsei Bank. At a share price of ¥1,449.0, SBI Shinsei Bank has seen short-term share price returns drift, with the 90 day share price return down 13.05% and the year to date share price return down 17.15%, while the 3 year total shareholder return...

AEON FantasyLTD (TSE:4343) has opened Q1 2027 with revenue of ¥24.6 billion and basic EPS of ¥49.84, alongside net income of ¥986 million, giving investors a fresh read on both top line scale and per share profitability. Over the past year the company has seen quarterly revenue move between ¥23.3 billion and ¥25.6 billion while basic EPS has ranged from a loss of ¥33.78 to a gain of ¥81.77, with trailing 12 month EPS at ¥183.53 and net income at ¥3.6 billion providing the broader earnings...

Belc (TSE:9974) has opened Q1 2027 with total revenue of ¥107.7 billion and basic EPS of ¥110.12, setting the tone for investors weighing the latest set of numbers. The company has seen quarterly revenue move from ¥103.7 billion in Q1 2026 to ¥107.7 billion in Q1 2027, while EPS shifted from ¥130.99 to ¥110.12 over the same period. This gives a clear look at how the top line and earnings per share are tracking year on year. With a trailing net profit margin of 2.9% versus 3.1% a year earlier...

It's been a sad week for Osaka Organic Chemical Industry Ltd. ( TSE:4187 ), who've watched their investment drop 13% to...

Fast Retailing Co., Ltd. ( TSE:9983 ) just released its quarterly report and things are looking bullish. The company...

Yokowo Co., Ltd. ( TSE:6800 ), might not be a large cap stock, but it received a lot of attention from a substantial...

Giken (TSE:6289) has just posted Q3 2026 numbers with revenue of ¥5,414 million and basic EPS of ¥11.27, giving investors a fresh read on how its earnings power is tracking after a year of sharp trailing growth. Over recent quarters, revenue has moved from ¥5,600 million in Q3 2025 to ¥8,908 million in Q4 2025, then to ¥7,562 million in Q1 2026 and ¥6,532 million in Q2 2026. Basic EPS has ranged from a loss of ¥17.84 in Q3 2025 to ¥39.15 in Q4 2025, ¥37.32 in Q1 2026 and ¥7.96 in Q2 2026...

YASKAWA Electric (TSE:6506) opened FY 2027 with Q1 revenue of ¥138.9 billion and basic EPS of ¥20.99, against trailing twelve month revenue of ¥555.5 billion and EPS of ¥130.06 that frame the latest print. Over recent quarters the company has seen revenue move from ¥125.6 billion in Q1 2026 to a peak of ¥146.9 billion in Q4 2026 before landing at ¥138.9 billion in Q1 2027. Quarterly EPS over the same period ranged from ¥26.81 to ¥43.55 before the latest ¥20.99 figure. This sets up a results...

Koshidaka Holdings (TSE:2157) has posted Q3 2026 revenue of ¥20.4 billion and basic EPS of ¥19.89, with trailing 12 month revenue of ¥77.4 billion and EPS of ¥65.21 framing the latest quarter in a wider earnings context. Over recent periods, the company has seen quarterly revenue move from ¥16.4 billion in Q1 2026 to ¥22.6 billion in Q2 2026 and then to ¥20.4 billion in Q3 2026. Basic EPS has shifted from ¥8.12 to ¥39.01 and then to ¥19.89, giving investors a clear read on how topline scale...

Aeon (TSE:8267) has released its Q1 2027 numbers, with revenue at ¥2.9 trillion and basic EPS of ¥4.99, set against trailing twelve month EPS of ¥33.82 that reflects reported earnings growth of 393.3% year over year. Over recent periods, revenue has moved from ¥2.57 trillion in Q1 2026 to ¥2.97 trillion in Q4 2026 and now ¥2.94 trillion in Q1 2027. Quarterly EPS has ranged from a loss of ¥2.54 per share in Q1 2026 to ¥30.22 in Q4 2026 before landing at ¥4.99 this quarter. Together these...

Amidst renewed geopolitical tensions and fluctuating energy prices, Asian markets have shown resilience, with sectors like technology and healthcare experiencing notable activity. In this climate of uncertainty, dividend stocks can offer a measure of stability and income potential for investors seeking to enhance their portfolios.

As geopolitical tensions and energy market volatility capture global attention, Asian markets are navigating these challenges with a focus on technology-driven growth, particularly in sectors like artificial intelligence and semiconductors. In this dynamic environment, high-growth tech stocks in Asia are gaining interest as investors look for companies that exhibit strong innovation capabilities and resilience against external economic pressures.

In its past Q1 FY2027 results, Takeuchi Mfg. reported double-digit sales growth but a decline in operating profit, pointing to margin pressure even as revenues expanded. The company kept its full-year forecast intact while planning a modest increase in its annual dividend to ¥220 per share, signaling an effort to balance growth investments with ongoing shareholder returns despite earnings headwinds. Next, we will examine how this combination of strong sales momentum and weaker...

On July 10, 2026, Yoshinoya Holdings Co., Ltd. announced a new share repurchase program of up to 850,000 shares, or 1.31% of its issued share capital, for ¥2,500,000,000, running through August 21, 2026 to support more flexible capital management. The buyback is closely tied to Yoshinoya’s plan to acquire a 70% stake in U.S.-based ramen chain Kizuki International LLC, positioning ramen as the group’s third core business and expanding its global footprint. We will now examine how the treasury...

With inflation trends easing in several major economies but energy costs and rate decisions still in focus, many investors are looking for a steadier way to seek income from equities. That is where the Dividend Powerhouses (3%+ Yield) theme comes in, targeting companies that offer more than a 5% yield that is described as well covered, growing and stable. In a world of mixed industrial data, volatile energy prices and central banks still weighing their next moves, these kinds of dividend...

Mizuho Financial Group has recently completed a series of large fixed-income offerings, including multiple US$-denominated floating and fixed-to-floating senior notes and ¥73.50 billion and ¥107.00 billion in subordinated unsecured notes due July 17, 2036. At the same time, the group finished a ¥39,573.65 million share repurchase program and refreshed its board, moves that together reshape its capital structure, funding mix, and governance profile. We’ll now examine how Mizuho’s recent wave...

AS ONE stock reaction to June sales update and board meeting AS ONE (TSE:7476) drew attention after reporting preliminary June 2026 net sales of ¥9,708 million compared with ¥8,524 million a year earlier, alongside a board meeting on share-based compensation using treasury shares. See our latest analysis for AS ONE. AS ONE's recent June sales update and share-based compensation plans come as the stock trades at ¥2,417, with an 11.1% 30-day share price return but a 5-year total shareholder...

In recent weeks, Eisai and its partners reported multiple developments, including UK regulators accepting marketing applications for insomnia drug lemborexant and ROS1+ lung cancer therapy taletrectinib, alongside extensive new clinical and real-world data on Alzheimer’s treatment lecanemab (Leqembi) at the 2026 Alzheimer’s Association International Conference. These updates, together with the extension of Eisai’s neuroscience collaboration with University College London to 2030, highlight...